Emerging Buruli Ulcer (Mycobacterium ulcerans infection)-Ambi among the Tiv People in North-Central Nigeria: A Public Health Concern Compounded by Traditional Believes and Ignorance.
DOI:
https://doi.org/10.37506/k9h77229Keywords:
Emerging, Buruli Ulcer, Nigeria, Concerned, Ignorance.Abstract
Background: Buruli ulcer is of public health concern particularly where the knowledge about the disease, the infectious agent, treatment and control is poor. An advent of an emerging wound ulcer epidemic was reported in North-central Nigeria in 2023. A study was then carried out between December 2023 to August 20204 among the Tiv people of North-central Nigeria who have reported an emerging strange wound ulcer disease among her population. We determined the prevalence and the knowledge about the infection among this population.
Methods: Descriptive epidemiological survey was conducted to determine the prevalence and the causative agent of the emerging wound ulcer among the Tiv people. Wound swabs were taken from the ulcers for laboratory confirmation that these infections were indeed those caused by Mycobacterium ulcerans.
Results: Of the 1,030 people assessed (392) 38.09 % Presented with a conspicuous wound ulcer, confirmed to be Buruli ulcer caused by M. ulcerans infection. This infection was very significant among the population cutting across all ages, occupation, gender, even educational levels and occupations. Traditional (88.6%) and spiritual (59.4%) means of infection were the dominant means by which the people believed infection can be acquired. Thus, the knowledge of the people about this infection is poor, believing that this infection is likely to be a traditional or spiritual disease rather than a normal infection.
Conclusion: Mycobacterium ulcerans infection (Buruli Ulcer) is highly prevalent and fast emerging among the Tiv people of North-central Nigeria. The knowledge about mode of infection and its means of spread is limited and very poor. There is the need for health authorities to intervene, mount health awareness campaigns on the disease, its mode of spread, prevention and control to ameliorate the sufferings of these people and restore confidence among them. This will again help to curb further spread of the infection.
References
MacCallum P, Tolhurst JC, Buckle G, Sissons HA. "A new mycobacterial infection in man". Journal of Pathology and Bacteriology, 1948; 60 (1): 93–122.
Igo JD, Murthy DP. "Mycobacterium ulcerans infections in Papua New Guinea: Correlation of clinical, histological, and microbiologic features". American Journal of Tropical Medicine and Hygiene, 1988;38 (2): 391–392.
van der Werf TS, Stienstra Y, Johnson RC, Phillips R, Adjei O, Fleischer B, Wansbrough-Jones MW, Johnson PD, Portaels F, van der Graaf WT, Asiedu K."Mycobacterium ulcerans disease". Bulletin of the World Health Organization, 2005;83 (10): 785–791.
World Health Organization. Treatment of Mycobacterium ulcerans Disease (Buruli Ulcer): Guidance for Health Workers(PDF). World Health Organization,2012.
WHO Global Health Observatory 2024. Number of confirmed cases of Buruli ulcer updated 2024-06-27. Global Health Observatory
Röltgen K, Cruz I, Ndung'u JM, Pluschke G. "Laboratory Diagnosis of Buruli Ulcer: Challenges and Future Perspectives"(PDF). In Pluschke G, Röltgen K (eds.). Buruli ulcer: Mycobacterium ulcerans disease. Cham, Switzerland: Springer, 2019; pp. 183–202.
Röltgen K, Pluschke G."Buruli ulcer: the efficacy of innate immune defense may be a key determinant for the outcome of infection with Mycobacterium ulcerans". Frontiers in Microbiology, 2020;11: 1018. doi:10.3389/fmicb.2020.01018.
Simpson H, Deribe K, Tabah EN, Peters A, Maman I, Frimpong M, Ampadu E, Phillips R, Sanderson P, Pullan RL, Cano J. "Mapping the global distribution of Buruli ulcer: a systematic review with evidence consensus". Lancet Global Health, 2019; 7 (7): e912–e922.
Bravo FG."Emerging infections: mimickers of common patterns seen in dermatopathology".
Modern Pathology,2019;33 (Suppl 1): 118–127.
Lavender CJ, Fyfe JA. Direct detection of Mycobacterium ulcerans in clinical specimens and
environmental samples. Methods Mol Biol, 2013; 943:201–216.
Guarner J."Buruli Ulcer: Review of a Neglected Skin Mycobacterial Disease". Journal of
Clinical Microbiology, 2018;56 (4): e01507–17.
Jacobsen KH, Padgett JJ. "Risk factors for Mycobacterium ulcerans infection". International
Journal of Infectious Diseases, 2010; 14 (8): e677–e681.
Tabah EN, Johnson CR, Degnonvi H, Pluschke G, Röltgen K."Buruli ulcer in Africa". In
Pluschke G, Röltgen K (eds.). Buruli ulcer: Mycobacterium ulcerans disease. Cham, Switzerland: Springer, 2019;pp. 43–60.
Röltgen K, Pluschke G."Buruli ulcer: history and disease burden". In Pluschke G, Röltgen K
(eds.). Buruli ulcer: Mycobacterium ulcerans disease. Cham, Switzerland: Springer, 2019; pp. 1–41.
Manry J. "Human genetics of Buruli ulcer". Human Genetics, 2020;139 (6–7): 847–853.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.